{"id":"W2413316483","doi":"10.1093/ajhp/59.10.941","title":"Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia","year":2002,"lang":"en","type":"article","venue":"American Journal of Health-System Pharmacy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Chemotherapy; Internal medicine; Cytarabine; Mitoxantrone; Calicheamicin; Surgery; Myeloid leukemia; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001000829,0.0003779164,0.001857704,0.0007840542,0.000167884,0.00002504892,0.0003497121,0.00004933004,0.00004566324],"category_scores_gemma":[0.00009731941,0.0002651016,0.0002476347,0.0008740136,0.0001946946,0.0002144148,0.00003695169,0.0007794271,0.00003122675],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005993979,"about_ca_system_score_gemma":0.00125928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001190302,"about_ca_topic_score_gemma":0.00001489073,"domain_scores_codex":[0.9957011,0.0004605184,0.001657472,0.0003628813,0.0008551387,0.0009628323],"domain_scores_gemma":[0.9964701,0.0003228043,0.001568547,0.0003847216,0.0006438903,0.0006099429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009263649,0.0007878906,0.7790176,0.000585287,0.0012772,0.0008357637,0.001693529,0.00006502945,0.0004328016,0.00001244984,0.00645423,0.1995746],"study_design_scores_gemma":[0.265502,0.07855526,0.5759693,0.003974353,0.001842961,0.008263216,0.006136653,0.01156712,0.002645609,0.000006611712,0.04358409,0.001952799],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988306,0.0004065578,0.0002451284,0.008825528,0.0001554015,0.001702314,0.00005432803,0.00005333063,0.0002513827],"genre_scores_gemma":[0.9953965,0.0003409137,0.002036609,0.001518447,0.0001376083,0.00004952914,0.00001827597,0.0001009167,0.0004012207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2562383,"threshold_uncertainty_score":0.9999801,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02757580737803302,"score_gpt":0.328183563977453,"score_spread":0.30060775659942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}